PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 44 filers reported holding PREVAIL THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $5,472,000 | -80.0% | 367,218 | -83.7% | 0.40% | -85.9% |
| Q1 2020 | $27,407,000 | -23.0% | 2,248,306 | 0.0% | 2.86% | -10.8% |
| Q4 2019 | $35,591,000 | +21.1% | 2,248,306 | -6.0% | 3.21% | -13.5% |
| Q3 2019 | $29,381,000 | -7.0% | 2,392,556 | 0.0% | 3.71% | +16.3% |
| Q2 2019 | $31,582,000 | – | 2,392,556 | – | 3.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|